"Tumor Intrinsic Features of Immunity," presented Luis Diaz, MD.
Luis Diaz, MD, is a renowned medical oncologist and translational scientist who is the head of solid tumor oncology at Memorial Sloan Kettering Cancer Center. His influential work in immuno-oncology led to the approval of checkpoint inhibitors for cancers that are deficient in the mismatch repair pathway, regardless of tissue of origin. He is also a leader in the application of circulating tumor DNA for cancer diagnosis and for the monitoring of therapeutic resistance. He is a member of President Biden’s National Cancer Advisory Board, a Fellow of the AACR Academy and a recipient of the Giants of Cancer Care award.
Breakthroughs in Cancer seminar series is one of the highest-profile seminar series for translational and clinical scientists in oncology. The series brings national leaders in cancer research to Stanford’s campus and highlights innovations across the spectrum of basic, translational, clinical, and population science. The series will be held in person on the second Tuesday of each month at Munzer Auditorium. #oncology #cancerresearch #sciencemedicine
Learn more about our Breakthroughs in Cancer seminar series: [ Ссылка ]
Learn more about the Stanford Cancer Institute: [ Ссылка ]
Follow the Stanford Cancer Institute
LinkedIn: [ Ссылка ]
Twitter: [ Ссылка ]
Subscribe to the Stanford Cancer Institute: [ Ссылка ]
